TY  - CHAP
M1  - Book, Section
TI  - Radiopharmaceuticals for Cardiovascular Imaging
A1  - Case, James A.
A1  - Heller, Gary V.
A2  - Heller, Gary V.
A2  - Hendel, Robert C.
PY  - 2022
T2  - Nuclear Cardiology: Practical Applications, 4e
AB  - KEY  POINTSIdeal  tracer  kinetics  is  important  in  understanding  the  strengths  and  limitations  of  current  and  future  tracers.Thallium-201  has  excellent  tracer  kinetics  but  is  limited  by  low-energy  emission  level  and  long  half-life,  and  therefore  is  not  recommended  for  routine  clinical  use.Technetium-based  tracers  offer  improved  image  quality  due  to  higher  emission  level  and  shorter  half-life  and  are  the  radiopharmaceuticals  of  choice  for  single-photon  emission  computerized  tomographic  nuclear  cardiology.The  most  common  positron  emission  tomography  tracer,  82Rb,  is  generator-derived  radiopharmaceutical,  with  excellent  blood  flow  characteristics  and  low  radiation,  making  it  suitable  for  most  clinical  practices.  
SN  - 
PB  - McGraw Hill LLC
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesscardiology.mhmedical.com/content.aspx?aid=1190155752
ER  -